192 related articles for article (PubMed ID: 33439758)
21. Simultaneous 68Ga-DOTATOC PET/MRI in patients with gastroenteropancreatic neuroendocrine tumors: initial results.
Beiderwellen KJ; Poeppel TD; Hartung-Knemeyer V; Buchbender C; Kuehl H; Bockisch A; Lauenstein TC
Invest Radiol; 2013 May; 48(5):273-9. PubMed ID: 23493121
[TBL] [Abstract][Full Text] [Related]
22. [Role of new radiation techniques (ultrasonography, computed tomography, and magnetic resonance imaging) in the diagnosis of incidentally discovered adrenal masses].
Denisova LB; Vorontsova SV; Eme'ianova LN
Vestn Rentgenol Radiol; 2004; (5):25-33. PubMed ID: 15704441
[TBL] [Abstract][Full Text] [Related]
23. Comparison of computed tomography histogram analysis and chemical-shift magnetic resonance imaging for adrenal mass characterization.
Halefoglu AM; Yasar A; Bas N; Ozel A; Erturk SM; Basak M
Acta Radiol; 2009 Nov; 50(9):1071-9. PubMed ID: 19863419
[TBL] [Abstract][Full Text] [Related]
24. Adrenal imaging.
Podgórska J; Cieszanowski A; Bednarczuk T
Endokrynol Pol; 2012; 63(1):71-81. PubMed ID: 22378102
[TBL] [Abstract][Full Text] [Related]
25. MRI and contrast enhanced ultrasound (CEUS) image fusion of renal lesions.
Rübenthaler J; Paprottka KJ; Marcon J; Reiser M; Clevert DA
Clin Hemorheol Microcirc; 2016; 64(3):457-466. PubMed ID: 27886003
[TBL] [Abstract][Full Text] [Related]
26. Radiologic evaluation of incidentally discovered adrenal masses.
Willatt JM; Francis IR
Am Fam Physician; 2010 Jun; 81(11):1361-6. PubMed ID: 20521756
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of adrenal masses with gadolinium enhancement and fat-suppressed MR imaging.
Semelka RC; Shoenut JP; Lawrence PH; Greenberg HM; Maycher B; Madden TP; Kroeker MA
J Magn Reson Imaging; 1993; 3(2):337-43. PubMed ID: 8448395
[TBL] [Abstract][Full Text] [Related]
28. Can Texture Analysis Be Used to Distinguish Benign From Malignant Adrenal Nodules on Unenhanced CT, Contrast-Enhanced CT, or In-Phase and Opposed-Phase MRI?
Ho LM; Samei E; Mazurowski MA; Zheng Y; Allen BC; Nelson RC; Marin D
AJR Am J Roentgenol; 2019 Mar; 212(3):554-561. PubMed ID: 30620676
[TBL] [Abstract][Full Text] [Related]
29. Differentiation of Benign From Metastatic Adrenal Masses in Patients With Renal Cell Carcinoma on Contrast-Enhanced CT.
Sasaguri K; Takahashi N; Takeuchi M; Carter RE; Leibovich BC; Kawashima A
AJR Am J Roentgenol; 2016 Nov; 207(5):1031-1038. PubMed ID: 27556736
[TBL] [Abstract][Full Text] [Related]
30. [Imaging of tumours of the adrenal gland].
Heinz-Peer G; Happel B; Prager G; Niederle B
Wien Klin Wochenschr; 2003; 115 Suppl 2():65-70. PubMed ID: 15518149
[TBL] [Abstract][Full Text] [Related]
31. Multislice computed tomography versus contrast-enhanced ultrasound in evaluation of complex cystic renal masses using the Bosniak classification system.
Clevert DA; Minaifar N; Weckbach S; Jung EM; Stock K; Reiser M; Staehler M
Clin Hemorheol Microcirc; 2008; 39(1-4):171-8. PubMed ID: 18503122
[TBL] [Abstract][Full Text] [Related]
32. Fetal suprarenal masses--assessing the complementary role of magnetic resonance and ultrasound for diagnosis.
Flanagan SM; Rubesova E; Jaramillo D; Barth RA
Pediatr Radiol; 2016 Feb; 46(2):246-54. PubMed ID: 26589304
[TBL] [Abstract][Full Text] [Related]
33. A comparative study of contrast-enhanced ultrasound and contrast-enhanced CT for the detection and characterization of renal masses.
Fang L; Bai K; Chen Y; Zhan J; Zhang Y; Qiu Z; Chen L; Wang L
Biosci Trends; 2021 Mar; 15(1):24-32. PubMed ID: 33642452
[TBL] [Abstract][Full Text] [Related]
34. The added value of contrast-enhanced ultrasound in evaluation of indeterminate small solid renal masses and risk stratification of cystic renal lesions.
Elbanna KY; Jang HJ; Kim TK; Khalili K; Guimarães LS; Atri M
Eur Radiol; 2021 Nov; 31(11):8468-8477. PubMed ID: 33912992
[TBL] [Abstract][Full Text] [Related]
35. Practical advantages of contrast-enhanced ultrasound in abdominopelvic radiology.
Ranganath PG; Robbin ML; Back SJ; Grant EG; Fetzer DT
Abdom Radiol (NY); 2018 Apr; 43(4):998-1012. PubMed ID: 29332247
[TBL] [Abstract][Full Text] [Related]
36. Uncommon adrenal masses: CT and MRI features with histopathologic correlation.
Guo YK; Yang ZG; Li Y; Deng YP; Ma ES; Min PQ; Zhang XC
Eur J Radiol; 2007 Jun; 62(3):359-70. PubMed ID: 17532488
[TBL] [Abstract][Full Text] [Related]
37. The indeterminate adrenal mass in patients with cancer.
Sahdev A; Reznek RH
Cancer Imaging; 2007 Oct; 7 Spec No A(Special issue A):S100-9. PubMed ID: 17921094
[TBL] [Abstract][Full Text] [Related]
38. Iodine and Fat Quantification for Differentiation of Adrenal Gland Adenomas From Metastases Using Third-Generation Dual-Source Dual-Energy Computed Tomography.
Martin SS; Weidinger S; Czwikla R; Kaltenbach B; Albrecht MH; Lenga L; Vogl TJ; Wichmann JL
Invest Radiol; 2018 Mar; 53(3):173-178. PubMed ID: 28990974
[TBL] [Abstract][Full Text] [Related]
39. Transarterial Chemoembolization of HCC with Radiopaque Microspheres: Evaluation with Computed Tomography and the Complementary Role of Contrast-Enhanced Ultrasonography.
Moschouris H; Malagari K; Dimakis A; Kiakidis T; Anagnostopoulou A
Cardiovasc Intervent Radiol; 2020 Jul; 43(7):1075-1083. PubMed ID: 32394087
[TBL] [Abstract][Full Text] [Related]
40. [Imaging of adrenal tumors].
Otal P; Grenier N; Chabbert V; Basseau F; Joffre F
J Radiol; 2002 Jun; 83(6 Pt 2):897-09, discussion 911-2. PubMed ID: 12218864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
